| Literature DB >> 32256307 |
Randriely Merscher Sobreira de Lima1, Barbara Barth2, Danusa Mar Arcego3, Euclides José de Mendonça Filho3,4, Andrew Clappison5, Sachin Patel5, Zihan Wang5, Irina Pokhvisneva5, Roberto Britto Sassi6, Geoffrey B C Hall7, Michael S Kobor8, Kieran J O'Donnell2,3,5, Ana Paula Santana de Vasconcellos Bittencourt9, Michael J Meaney2,3,5,10, Carla Dalmaz1, Patrícia Pelufo Silveira2,3,5.
Abstract
Variations in serotoninergic signaling have been related to behavioral outcomes. Alterations in the genome, such as DNA methylation and histone modifications, are affected by serotonin neurotransmission. The amygdala is an important brain region involved in emotional responses and impulsivity, which receives serotoninergic input. In addition, studies suggest that the serotonin transporter gene network may interact with the environment and influence the risk for psychiatric disorders. We propose to investigate whether/how interactions between the exposure to early life adversity and serotonin transporter gene network in the amygdala associate with behavioral disorders. We constructed a co-expression-based polygenic risk score (ePRS) reflecting variations in the function of the serotonin transporter gene network in the amygdala and investigated its interaction with postnatal adversity on attention problems in two independent cohorts from Canada and Singapore. We also described how interactions between ePRS-5-HTT and postnatal adversity exposure predict brain gray matter density and variation in DNA methylation across the genome. We observed that the expression-based polygenic risk score, reflecting the function of the amygdala 5-HTT gene network, interacts with postnatal adversity, to predict attention and hyperactivity problems across both cohorts. Also, both postnatal adversity score and amygdala ePRS-5-HTT score, as well as their interaction, were observed to be associated with variation in DNA methylation across the genome. Variations in gray matter density in brain regions linked to attentional processes were also correlated to our ePRS score. These results confirm that the amygdala 5-HTT gene network is strongly associated with ADHD-related behaviors, brain cortical density, and epigenetic changes in the context of adversity in young children.Entities:
Keywords: ADHD; DNA methylation; attention; ePRS; early environment; impulsivity; parallel independent component analysis; serotonin transporter
Year: 2020 PMID: 32256307 PMCID: PMC7093057 DOI: 10.3389/fnins.2020.00198
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Genes selected for composing the genetic score (5-HTT-ePRS).
| ADAMTS7 | ENSG00000136378 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
| ATAD2B | ENSG00000119778 | Atpase family, AAA domain containing 2B |
| AURKA | ENSG00000087586 | Aurora kinase A |
| CHD7 | ENSG00000171316 | Chromodomain helicase DNA binding protein 7 |
| CHRNB4 | ENSG00000117971 | Cholinergic receptor, nicotinic, beta 4 |
| CNGA3 | ENSG00000144191 | Cyclic nucleotide gated channel alpha 3 |
| COL3A1 | ENSG00000168542 | Collagen, type III, alpha 1 |
| DLL3 | ENSG00000090932 | Delta-like 3 (Drosophila) |
| DNMT3B | ENSG00000088305 | DNA (cytosine-5-)-methyltransferase 3 beta |
| EHMT2 | ENSG00000204371 | Euchromatic histone-lysine N-methyltransferase 2 |
| EIF4EBP1 | ENSG00000187840 | Eukaryotic translation initiation factor 4E binding protein 1 |
| ELN | ENSG00000049540 | Elastin |
| GAS5 | ENSG00000234741 | Growth arrest-specific 5 (non-protein coding) |
| GTSE1 | ENSG00000075218 | G-2 and S-phase expressed 1 |
| HMGB1 | ENSG00000189403 | High mobility group box 1 |
| HNRNPA1 | ENSG00000135486 | Heterogeneous nuclear ribonucleoprotein A1 |
| LRRC26 | ENSG00000184709 | Leucine rich repeat containing 26 |
| NBEAL1 | ENSG00000144426 | Neurobeachin-like 1 |
| NHLH1 | ENSG00000171786 | Nescient helix loop helix 1 |
| PKN1 | ENSG00000123143 | Protein kinase N1 |
| PRKDC | ENSG00000253729 | Protein kinase, DNA-activated, catalytic polypeptide |
| PTK7 | ENSG00000112655 | PTK7 protein tyrosine kinase 7 |
| RAD54L | ENSG00000085999 | RAD54-like ( |
| RBM12B | ENSG00000183808 | RNA binding motif protein 12B |
| RBM4 | ENSG00000173933 | RNA binding motif protein 4 |
| RPL27A | ENSG00000166441 | Ribosomal protein l27a |
| RPL36 | ENSG00000130255 | Ribosomal protein L36 |
| SCLT1 | ENSG00000151466 | Sodium channel and clathrin linker 1 |
| SFRP1 | ENSG00000104332 | Secreted frizzled-related protein 1 |
| TEAD2 | ENSG00000074219 | TEA domain family member 2 |
| TRIM58 | ENSG00000162722 | Tripartite motif containing 58 |
| TSKU | ENSG00000182704 | Tsukushi small leucine rich proteoglycan homolog ( |
| USP49 | ENSG00000164663 | Ubiquitin specific peptidase 49 |
| WDR62 | ENSG00000075702 | WD repeat domain 62 |
| ZCCHC7 | ENSG00000147905 | Zinc finger, CCHC domain containing 7 |
Figure 1Flowchart depicting the steps involved in creating the expression-based polygenic risk score based on genes co-expressed with serotonin transporter gene in amygdala using gene co-expression databases: GeneNetwork was used to generate a co-expression matrix with 5-HTT gene in the amygdala in mice (absolute value of the co-expression correlation r ≥ 0.5); BrainSpan was then used to identify consensus human transcripts from this list; BrainSpan was also used for selecting genes differentially expressed at ≥1.5-fold during child and fetal development as compared to adulthood within the same brain areas. Based on their functional annotation in the National Center for Biotechnology Information, U.S. National Library of Medicine, we gathered all the existing SNPs from these genes and subjected this list of SNPs to linkage disequilibrium clumping. We used a count function of the number of alleles at a given SNP (rs1, rs2…) weighted by the estimated effect of the genotype associated with gene expression. The sum of these values from the total number of SNPs provides the amygdala 5-HTT ePRS score.
Description of the baseline characteristics of the MAVAN and GUSTO samples according to high and low amygdala ePRS-5-HTT.
| Sex—male | 49.7% (72) | 53.6% (37) | 46.1% (35) | 0.36 |
| Maternal age at birth (years) | 30.60 (4.62) | 30.20 (4.58) | 30.95 (4.65) | 0.33 |
| Gestational age (weeks) | 39.18 (1.21) | 39.25 (1.25) | 39.12 (1.17) | 0.52 |
| Birth weight (grams) | 3,308 (452) | 3,380 (477) | 3,242 (420) | 0.06 |
| Breastfeeding (months) | 7.53 (4.80) | 7.54 (4.61) | 7.52 (4.99) | 0.98 |
| Smoking during pregnancy | 12.4% (18) | 10.1% (7) | 14.5% (11) | 0.43 |
| Maternal education—University degree or above | 57.9% (84) | 62.3% (43) | 53.9% (41) | 0.30 |
| Low family income | 15.2% (20) | 15.4% (10) | 14.9% (10) | 0.94 |
| Sex - male | 51.9% (208) | 50.3% (99) | 53.4% (109) | 0.52 |
| Maternal age at birth (years) | 31.21 (5.12) | 31.33 (5.27) | 31.1 (4.98) | 0.65 |
| Gestational age (weeks) | 38.48 (1.27) | 38.43 (1.36) | 38.53 (1.18) | 0.39 |
| Birth weight (grams) | 3,139 (425) | 3,119 (420) | 3,158 (430) | 0.36 |
| Breastfeeding for at least 3 months | 61.0% (241) | 66.1% (127) | 56.2% (114) | 0.042 |
| Smoking during pregnancy | 2.0% (8) | 1.0% (2) | 2.9% (6) | 0.16 |
| Maternal education—University degree or above | 35.4% (142) | 39.1% (77) | 31.9% (65) | 0.13 |
| Household income < SG$2,000 | 13.5% (54) | 11.2% (22) | 15.7% (32) | 0.18 |
Numbers are presented as mean (SD) or percentage (number of participants).
Significant differences between low and high ePRS groups (p <0.05).
Figure 2Interaction between Postnatal Adversity Score and amygdala-based ePRS-5-HTT on: (A) ADHD problems 48 and (B) 60 months (N = 137), (C) Attention Problems at 48 months (D) Externalizing Problem at 48 months (E) and 60 months. Increased postnatal adversity exposure is associated with more problematic behavior outcomes as the ePRS decreases. MAVAN cohort, N = 125–137.
Results of interactions between the adversity score and the amygdala-based ePRS-5-HTT on CBCL behavior of children in MAVAN and GUSTO cohorts; and evidence of differential susceptibility.
| Attention problems 48 m | β = −39.07, | Attention Problems 48m | ||
| ADHD problems 48 m | ADHD Problems 48m | |||
| Externalizing problems 48 m | Externalizing Problems 48m | |||
| Attention problems 60 m | ||||
| ADHD problems 60 m | ||||
| Externalizing problems 60 m | ||||
| Attention problems 48 m | MAVAN | 0.17 | 0.60 | Yes |
| ADHD problems 48 m | MAVAN | 0.15 | 0.60 | Yes |
| ADHD problems 60 m | MAVAN | 0.15 | 0.61 | Yes |
| Externalizing problems 48 m | MAVAN | 0.17 | 0.60 | No |
| Externalizing problems 60 m | MAVAN | 0.27 | 0.80 | No |
| Attention problems 48 m | GUSTO | 0.85 | 0.43 | Yes |
| ADHD problems 48 m | GUSTO | 0.09 | 0.43 | No |
| Externalization problems 48 m | GUSTO | 0.12 | 0.78 | Yes |
PoI and PA values close to 0.50 suggest strong evidence for differential susceptibility.
Significant interactions between the adversity score and the amygdala-based ePRS-5-HTT (p < 0.05).
Figure 3Interaction effect between Postnatal Adversity Score and amygdala-based ePRS-5-HTT on: (A) ADHD problems at 4 years, (B) attention problems at 4 years, and (C) Externalizing Problems at 4 years. Increased postnatal adversity exposure is associated with outcomes related to more Behavioral problems as ePRS decreases. GUSTO cohort, N = 401.
Figure 4Variations in DNA methylation levels were predicted by postnatal adversity score, ePRS-5-HTT, and the interaction between postnatal adversity score and ePRS-5-HTT. Each variable on chart denotes one model. AIC was used to compare three models for each CpG and select the best one. Percentages on chart represent the number of CpGs that are best explained (lowest AIC) by a specific model. All models were adjusted for population stratification and sex.
Figure 5Genes interactions of the amygdala 5-HTT co-expression network. The border of the genes represents the out-degree of these nodes, meaning the number of outgoing relationships. The larger the border, the stronger the relationship of the gene to other genes. The size of the nodes represents the in-degree, i.e., the number of incoming relationships with neighbors. The bigger the node, the higher the relationships of other genes to the target gene. The edges represent co-expression. Color and thickness were used to identify the most co-expressed genes, darker, and thicker represent higher co-expression.
Figure 6Co-expression of the genes included in the ePRS-5-HTT in the amygdala in the (A) infancy and early childhood, and (B) adulthood periods in humans. Each vertical line represents correlation with a unique gene. Genes from the same expression quantification tend to cluster together and could be visualized in red (positive correlation), or blue (negative correlation) patterns. Infancy and early childhood period ranges from 0 to 4 years of age (N = 7); Adulthood ranges from 20 to 40 years (N = 6). Data for this analysis was extracted from BrainSpan.
Pathway Maps and Gene Ontology Processes related to genes included in the expression-based polygenic risk score of the 5-HTT in the amygdala.
| Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression | 0.0009 | 0.046 |
| DNA damage_Mismatch repair | 0.001 | 0.046 |
| Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing | 0.0017 | 0.046 |
| Transcription_Sin3 and NuRD in transcription regulation | 0.0017 | 0.046 |
| Canonical Notch signaling pathway in colorectal cancer | 0.0023 | 0.046 |
| Signal transduction_Adenosine A2A receptor signaling pathway | 0.003 | 0.046 |
| Translation_Translation regulation by Alpha-1 adrenergic receptors | 0.003 | 0.046 |
| TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE | 0.003 | 0.046 |
| Transcription_Epigenetic regulation of gene expression | 0.003 | 0.048 |
| Chromosome organization | 0.00000004 | 0.00005 |
| DNA geometric change | 0.0000001 | 0.00008 |
| Nervous system development | 0.0000001 | 0.00009 |
| Chromatin organization | 0.0000002 | 0.00010 |
| Generation of neurons | 0.0000004 | 0.00016 |
| Cellular response to stress | 0.0000005 | 0.00016 |
| System development | 0.0000005 | 0.00016 |
| Neurogenesis | 0.000001 | 0.00023 |
| DNA conformation change | 0.000002 | 0.00027 |
| Developmental process | 0.000017 | 0.00109 |
| DNA methylation on cytosine within a CG sequence | 0.00004 | 0.00162 |
| Positive regulation of DNA ligation | 0.00004 | 0.00162 |
Figure 7Epifactors included in the expression-based polygenic risk score of the 5-HTT in the amygdala: (1) Genes classified as epifactors, involved in histone phosphorylation and methylation, chromatin remodeling, and DNA methylation; (2) Cell classes in the brain where these epifactors are expressed. Each graphic represents a gene: (A) PRKDC, (B) PKN1, (C) EHMT2, (D) AURKA, (E) ATAD2B, (F) USP49, (G) DNMT3B, (H) RAD54L, (I) HMGB1, and (J) CHD7.
Figure 8Enrichment analysis performed using Panther (http://pantherdb.org/): Enrichment for (A) molecular functions, (B) biological processes, (C) protein classes, (D) cell components, and (E) pathways.
Figure 9A bar plot of the mean loading coefficients of brain magnetic resonance imaging (MRI) component and genetic component. Student's t-test was performed to compare loading coefficients means between groups of high and low adversity score for SNPs (single nucleotide polymorphisms) and MRI.
Significant brain regions associated with gray matter density and SNP-based ePRS-5-HTT data on MRI component 5 by Parallel ICA.
| Middle temporal gyrus | 19 | 0.4/0.6 | 5.1 (−53, −53, −9)/5.2 (62, −28, −10) |
| Sub-gyral | 0.4/0.4 | 5.0 (−34, −40, 38)/6.0 (45, −47, −9) | |
| Precuneus | 7, 31 | 0.4/0.2 | 5.0 (−22, −61, 38)/4.0 (9, −53, 44) |
| Middle frontal gyrus | 6, 8, 10 | 0.3/0.6 | 3.9 (−22, 22, 38)/4.7 (18, −11, 61) |
| Inferior temporal gyrus | 19, 20, 21, 37 | 0.3/0.4 | 4.9 (−34, −3, −36)/5.3 (49, −57, −2) |
| Postcentral gyrus | 3, 4 | 0.3/0.4 | 4.7 (−50, −19, 20)/4.2 (55, −20, 37) |
| Fusiform gyrus | 19, 20, 37 | 0.3/0.3 | 5.5 (−53, −11, −23)/4.3 (48, −49, −13) |
| Superior frontal gyrus | 6, 10 | 0.3/0.3 | 4.8 (−24, 51, −5)/4.5 (18, −11, 66) |
| Cerebellar declive | 0.3/0.2 | 4.9 (−37, −71, −22)/5.6 (30, −77, −20) | |
| Lingual gyrus | 18 | 0.3/0.2 | 4.5 (−12, −77, 0)/4.0 (27, −64, −6) |
| Superior temporal gyrus | 42 | 0.3/0.1 | 4.3 (−55, −34, 16)/3.8 (61, −34, 18) |
| Middle occipital gyrus | 0.2/0.3 | 5.4 (−22, −92, 3)/5.2 (42, −70, −7) | |
| Supramarginal gyrus | 40 | 0.2/0.0 | 3.9 (−45, −50, 25)/−999.0 (0, 0, 0) |
| Precentral gyrus | 6 | 0.1/0.3 | 4.1 (−49, 8, 8)/5.1 (33, −19, 48) |
| Medial frontal gyrus | 10, 11 | 0.1/0.3 | 3.7 (−7, 39, 30)/4.2 (10, 51, 2) |
| Middle frontal gyrus | 6, 9, 10, 11, 46 | 0.8/1.2 | 4.8 (−30, 8, 52)/5.5 (36, 18, 39) |
| Inferior parietal lobule | 39, 40 | 0.6/0.6 | 5.5 (−48, −47, 42)/5.4 (31, −53, 45) |
| Inferior frontal gyrus | 9, 44, 45, 47 | 0.6/0.6 | 4.9 (−48, 32, 0)/5.0 (46, 4, 30) |
| Sub-gyral | 0.5/0.4 | 5.4 (−31, −51, 38)/4.8 (25, −35, 52) | |
| Superior temporal gyrus | 13, 22, 39 | 0.4/0.2 | 5.1 (−58, −40, 19)/3.8 (64, −26, 10) |
| Medial frontal gyrus | 6, 10, 11 | 0.4/0.1 | 5.2 (−13, 4, 59)/4.1 (16, 62, −4) |
| Precuneus | 7 | 0.3/0.6 | 4.3 (−4, −61, 31)/4.2 (13, −48, 55) |
| Superior frontal gyrus | 8, 9, 11 | 0.3/0.5 | 4.6 (−34, 46, 16)/5.1 (9, 58, 22) |
| Precentral gyrus | 9, 44 | 0.3/0.1 | 6.5 (−48, 19, 9)/4.4 (39, 8, 37) |
| Postcentral gyrus | 2, 3 | 0.3/0.1 | 5.0 (−25, −34, 53)/4.6 (27, −31, 55) |
| Supramarginal gyrus | 40 | 0.2/0.3 | 4.0 (−50, −48, 33)/4.3 (55, −48, 30) |
| Middle temporal gyrus | 37 | 0.2/0.2 | 4.0 (−50, −65, 6)/5.0 (49, −51, 7) |
| Superior parietal lobule | 7 | 0.2/0.1 | 3.9 (−40, −56, 48)/4.1 (31, −56, 48) |
Does not have a close match to a particular brodmann area.
Dominant SNPs (Z-Threshold = 2.5) associated with gray matter density on SNP component 12 by Parallel ICA.
| TRIM58 | rs61857833 | 8.86 |
| TRIM58 | rs9787332 | 6.85 |
| TRIM58 | rs55634584 | 6.65 |
| ZCCHC7 | rs68046074 | 5.24 |
| TRIM58 | rs34268703 | 4.87 |
| WDR62 | rs117559678 | −4.84 |
| TRIM58 | rs2101702 | −3.42 |
| CNGA3 | rs4851129 | −3.30 |
| COL3A1 | rs3134656 | 3.03 |
| WDR62 | rs139494942 | 2.77 |
| GTSE1 | rs79334853 | 2.74 |
| TRIM58 | rs4925574 | 2.64 |
| GTSE1 | rs3817874 | 2.53 |
| TRIM58 | rs112538341 | 2.53 |